ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NPTH Enpath Medical (MM)

0.00
0.00 (0.00%)
After Hours
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Enpath Medical (MM) NASDAQ:NPTH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Enpath Medical Announces Second Quarter 2006 Earnings Release and Conference Call Date

12/07/2006 5:11pm

PR Newswire (US)


Enpath (NASDAQ:NPTH)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Enpath Charts.
MINNEAPOLIS, July 12 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH) announced today that it will release its second quarter 2006 financial results before the market opens on Thursday, July 20, 2006. The management team of Enpath Medical will host a conference call to discuss the results beginning at 1:30 P.M. Central Time, also on Thursday, July 20, 2006. To participate, please call 800-257-2101 for domestic callers and 303-262-0066 for international callers. A recording of the conference call will be available approximately one hour after the conclusion of the call and will be accessible for seven days. To access the replay, please dial 1-800-405-2236 for domestic callers and 303- 590-3000 for international callers; please reference the passcode 11066187#. The conference call will also be webcast live on the company's web site, http://www.enpathmed.com/ , and may be accessed by clicking on the 2nd Quarter 2006 Earnings Call icon. An audio replay will be archived on the Enpath website for one year. About Enpath Medical Enpath Medical, Inc., headquartered in Plymouth, Minnesota, is a leader in the design, development, manufacture and marketing of percutaneous delivery systems and stimulation leads technologies. Its proprietary products include venous vessel introducers, articulating and fixed curve delivery catheters, epicardial and endocardial stimulation leads, and other products for use in pacemaker, defibrillator, catheter and infusion port procedures as well as neuromodulation markets. Its products, which are primarily finished goods, are sold worldwide through partnering relationships with other medical device companies. DATASOURCE: Enpath Medical, Inc. CONTACT: Investors, Doug Sherk, or, Jennifer Beugelmans, +1-415-896-6820, or, Media, Steve DiMattia, +1-646-277-8706, both of EVC Group Web site: http://www.enpathmed.com/

Copyright

1 Year Enpath Chart

1 Year Enpath Chart

1 Month Enpath Chart

1 Month Enpath Chart

Your Recent History

Delayed Upgrade Clock